Abbott Laboratories to acquire Vysis.
D001709:Biotechnology / Q000191:economics / Q000639:trends*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D025202:Molecular Diagnostic Techniques; D009369:Neoplasms / Q000175:diagnosis